PGMN3
HealthcareEmpreendimentos Pague Menos
Price
R$2.41
−2.82%
P/E
4.82
P/VP
0.52
Dividend yield, 12 months
10.64%
Last income payment
R$0.26
12/26/2025
Market cap
R$1.7B
Daily liquidity
R$40.0M
Price over the last year
| Price | |
|---|---|
| 11/12/2025 | R$4.57 |
| 11/19/2025 | R$5.00 |
| 11/27/2025 | R$5.50 |
| 12/4/2025 | R$6.28 |
| 12/11/2025 | R$6.25 |
| 12/18/2025 | R$6.26 |
| 12/29/2025 | R$5.98 |
| 1/7/2026 | R$6.44 |
| 1/14/2026 | R$6.55 |
| 1/21/2026 | R$6.36 |
| 1/28/2026 | R$6.83 |
| 2/4/2026 | R$6.56 |
| 2/11/2026 | R$6.75 |
| 2/20/2026 | R$7.54 |
| 2/27/2026 | R$6.97 |
| 3/6/2026 | R$6.20 |
| 3/13/2026 | R$6.04 |
| 3/20/2026 | R$5.99 |
| 3/27/2026 | R$6.12 |
| 4/6/2026 | R$5.69 |
| 4/13/2026 | R$5.87 |
| 4/20/2026 | R$5.79 |
| 4/28/2026 | R$5.53 |
| 5/6/2026 | R$5.27 |
| 5/13/2026 | R$4.72 |
| 5/20/2026 | R$4.72 |
| 5/27/2026 | R$4.50 |
| 6/3/2026 | R$4.04 |
| 6/11/2026 | R$3.98 |
| 6/18/2026 | R$3.72 |
| 6/25/2026 | R$3.81 |
| 7/2/2026 | R$3.66 |
| 7/9/2026 | R$3.66 |
| 7/16/2026 | R$3.49 |
| 7/23/2026 | R$3.37 |
| 7/30/2026 | R$3.19 |
| 8/6/2026 | R$3.40 |
| 8/13/2026 | R$3.31 |
| 8/20/2026 | R$3.22 |
| 8/27/2026 | R$3.43 |
| 9/3/2026 | R$3.75 |
| 9/11/2026 | R$3.80 |
| 9/18/2026 | R$3.69 |
| 9/25/2026 | R$3.36 |
| 10/2/2026 | R$3.70 |
| 10/9/2026 | R$5.50 |
| 10/19/2026 | R$5.34 |
| 10/26/2026 | R$2.81 |
| 11/3/2026 | R$2.54 |
| 11/10/2026 | R$2.38 |
| 11/12/2026 | R$2.41 |
Income paid per share
| Income | |
|---|---|
| 12/26/2025 | R$0.26 |
Summary of PGMN3
- The P/E of 4.82 is below the sector median (11.20).
- The dividend yield of 10.64% is above the sector median (4.86%).
- It made a profit in all of the last 4 reported years.
- The price is 200.83% below the Graham fair price.
Sentences generated automatically from the numbers on this page. They are not a recommendation to buy or sell.
Profitability and debt
ROE
10.59%
Net margin
2.10%
Gross margin
32.30%
Operating margin
6.76%
EBITDA margin
6.01%
Gross debt/equity
1.02x
Net debt/EBITDA
3.59x
EV/EBITDA
5.53x
Current ratio
1.78
Fair price
Graham fair price
R$7.25
Price 200.8% below this value
Bazin price ceiling
R$4.28
Price 77.6% below this value
Graham: square root of 22.5 × earnings per share × book value per share. Bazin: dividends paid in 12 months ÷ 6%. They are simple study methods that ignore the growth and risk of the company; they are not a recommendation.
Annual income statement
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | R$9.8B | R$12.0B | R$13.6B | R$16.0B |
| Gross profit | R$0.0 | R$0.0 | R$0.0 | R$0.0 |
| EBIT | R$0.0 | R$0.0 | R$0.0 | R$0.0 |
| Net income | R$263.7M | R$2.5M | R$103.1M | R$260.3M |
- Annual revenue growth:17.80%
- Annual profit growth:-0.43%
- Profitable years:4 of 4
Amounts in Brazilian reais, from the published annual statements (source: Yahoo Finance). Balance sheet and cash flow are not available from this source.
Comparison with the sector
Median of the 19 companies in the healthcare sector with the indicator available.
| Indicator | PGMN3 | Sector median | Rank |
|---|---|---|---|
| P/E | 4.82 | 11.20 | Higher than 1 of 16 |
| P/VP | 0.52 | 1.23 | Higher than 3 of 18 |
| Dividend yield, 12 months | 10.64% | 4.86% | Higher than 10 of 13 |
| ROE | 10.59% | 10.86% | Higher than 8 of 18 |
How to read the indicators
P/E
How many years of current earnings the price pays for. The lower, the cheaper the stock relative to profit, but falling or one-off profit distorts the number.
P/B
Compares the price with the book value per share. Below 1 means a discount to book value; above 1, a premium.
Dividend yield
Dividends paid in the last 12 months divided by the price. Extraordinary dividends can inflate the number.
ROE
Profit divided by shareholders equity: shows what the company earns on shareholder capital. Highly indebted companies can show a high ROE through leverage.
Net debt/EBITDA
How many years of operating cash generation it would take to repay net debt. Above 3 usually calls for attention. It does not apply well to banks.
About PGMN3
The stock PGMN3 of Empreendimentos Pague Menos trades on B3 and is in the healthcare sector, priced at R$2.41 with a market cap of R$1.7B. The P/E is 4.82, the P/B is 0.52 and the 12-month dividend yield is 10.64%.
Fund data
- Ticker
- PGMN3
- Official name
- Empreendimentos Pague Menos S.A.
- Category
- Healthcare
Frequently asked questions
How much does PGMN3 pay in dividends?
Over the last 12 months the stock PGMN3 (Empreendimentos Pague Menos) had a dividend yield of 10.64%, with the last payout of R$0.26 per share. The price is R$2.41.
Is PGMN3 expensive or cheap by P/E?
The P/E is 4.82: the price is 4.82 times earnings per share over the last 12 months. Compare it with companies in the same sector and look at earnings growth before drawing conclusions.
What does the P/B of PGMN3 show?
The P/B is 0.52: the price is 0.52 times book value per share. Below 1 means a discount to book value and above 1 a premium.
Other funds in the healthcare category
| Stock | Price | P/E | P/VP | DY 12m |
|---|---|---|---|---|
| RDOR3Rede D'Or São Luiz | R$34.24 | 15.56 | 3.60 | 12.3% |
| SAUD3Bradsaúde | R$16.29 | 11.47 | 2.42 | 4.6% |
| RADL3Raia Drogasil | R$14.26 | 18.28 | 3.30 | 3.2% |
| HYPE3Hypera | R$22.21 | 8.26 | 1.05 | 4.9% |
| FLRY3Fleury | R$21.05 | 14.72 | 2.29 | 6.2% |
| DASA3Diagnósticos da América | R$3.63 | — | 0.65 | — |
Sources: Yahoo Finance (price, income, volume, earnings and book value per share, delayed). Information for tracking only, not investment advice. Check the data at the source before deciding.
Track your investments
Add PGMN3 to your JuntaTudo portfolio and follow its price, income and price alerts together with the rest of your wealth.
Your money, all in one place
Accounts, cards, investments and goals in a single app. Market is a gift from JuntaTudo.
- Accounts and cards
- Investments and goals
- Juntin, the AI that puts it together

